Deep Track Capital, LP
- SEC CIK
- 0001856083
- 最新申報
- 2026/8/14
2022 年第 3 季持倉
持倉截至 2022/9/30，2022/11/14 申報。只含多頭部位，變化是跟 2022 年第 2 季比股數。
- 持股檔數
- 60
- 較 2022 年第 2 季 +11
- 總值
- $20.2 億
- 較 2022 年第 2 季 +$5.78 億 (+39.9%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| ISEEIVERIC bio, Inc. | COM | 7,000,000 | $1.26 億 | 6.2% | +2,500,000+55.6% | 加碼 | 歷史 |
| JAZZJazz Pharmaceuticals plc | SHS USD | 861,000 | $1.15 億 | 5.7% | +361,000+72.2% | 加碼 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 4,000,000 | $9,856 萬 | 4.9% | +419,300+11.7% | 加碼 | 歷史 |
| NVCRNovoCure Ltd | ORD SHS | 1,293,761 | $9,830 萬 | 4.9% | −47,539−3.5% | 減碼 | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 1,462,800 | $9,053 萬 | 4.5% | +1,462,800 | 新進 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 800,000 | $8,261 萬 | 4.1% | +800,000 | 新進 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 2,369,210 | $6,759 萬 | 3.3% | +2,369,210 | 新進 | 歷史 |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 2,900,000 | $6,745 萬 | 3.3% | 00.0% | 不變 | 歷史 |
| BMRNBiomarin Pharmaceutical Inc | COM | 738,863 | $6,263 萬 | 3.1% | +84,498+12.9% | 加碼 | 歷史 |
| KDNYChinook Therapeutics, Inc. | COM | 3,000,000 | $5,898 萬 | 2.9% | −430,110−12.5% | 減碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 9,860,246 | $5,502 萬 | 2.7% | +405,246+4.3% | 加碼 | 歷史 |
| AGENAgenus Inc | COM NEW | 26,325,000 | $5,397 萬 | 2.7% | +4,083,583+18.4% | 加碼 | 歷史 |
| BEAMBeam Therapeutics Inc. | COM | 1,000,000 | $4,764 萬 | 2.4% | −250,000−20.0% | 減碼 | 歷史 |
| KURAKura Oncology, Inc. | COM | 3,186,083 | $4,352 萬 | 2.2% | −511,886−13.8% | 減碼 | 歷史 |
| AUPHAurinia Pharmaceuticals Inc. | COM | 5,677,372 | $4,269 萬 | 2.1% | +5,677,372 | 新進 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 3,184,200 | $4,044 萬 | 2.0% | −315,800−9.0% | 減碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 1,970,290 | $4,041 萬 | 2.0% | +800,000+68.4% | 加碼 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 3,127,667 | $3,794 萬 | 1.9% | +420,005+15.5% | 加碼 | 歷史 |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 3,778,818 | $3,790 萬 | 1.9% | +678,818+21.9% | 加碼 | 歷史 |
| ESPREsperion Therapeutics, Inc. | COM | 5,636,587 | $3,777 萬 | 1.9% | −363,413−6.1% | 減碼 | 歷史 |
| NKTXNkarta, Inc. | COM | 2,814,844 | $3,704 萬 | 1.8% | 00.0% | 不變 | 歷史 |
| HRTXHeron Therapeutics, Inc. | COM | 8,548,387 | $3,607 萬 | 1.8% | +8,548,387 | 新進 | 歷史 |
| EWTXEdgewise Therapeutics, Inc. | COM | 3,374,394 | $3,320 萬 | 1.6% | +3,374,394 | 新進 | 歷史 |
| FATEFate Therapeutics Inc | COM | 1,311,113 | $2,938 萬 | 1.5% | −706,892−35.0% | 減碼 | 歷史 |
| PLRXPliant Therapeutics, Inc. | COM | 1,399,744 | $2,924 萬 | 1.4% | +1,399,744 | 新進 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 2,829,094 | $2,891 萬 | 1.4% | +2,829,094 | 新進 | 歷史 |
| ALLKAllakos Inc. | COM | 4,518,575 | $2,765 萬 | 1.4% | +4,518,575 | 新進 | 歷史 |
| AKROAkero Therapeutics, Inc. | COM | 790,926 | $2,693 萬 | 1.3% | +790,926 | 新進 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 2,053,621 | $2,676 萬 | 1.3% | −382,543−15.7% | 減碼 | 歷史 |
| VERVVerve Therapeutics, Inc. | COM | 775,000 | $2,662 萬 | 1.3% | +775,000 | 新進 | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 1,824,000 | $2,647 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| FDMT4D Molecular Therapeutics, Inc. | COM | 3,196,642 | $2,570 萬 | 1.3% | +56,642+1.8% | 加碼 | 歷史 |
| THRDThird Harmonic Bio, Inc. | COM | 1,268,220 | $2,406 萬 | 1.2% | +1,268,220 | 新進 | 歷史 |
| GBTGlobal Blood Therapeutics, Inc. | COM | 326,600 | $2,224 萬 | 1.1% | −3,320,090−91.0% | 減碼 | 歷史 |
| VIGLVigil Neuroscience, Inc. | COM | 2,363,188 | $2,151 萬 | 1.1% | +2,054,795+666.3% | 加碼 | 歷史 |
| ALBOAlbireo Pharma, Inc. | COM | 1,110,624 | $2,150 萬 | 1.1% | +1,110,624 | 新進 | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 9,325,540 | $2,089 萬 | 1.0% | −2,145,741−18.7% | 減碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 1,053,000 | $2,068 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| DICEDICE Therapeutics, Inc. | COM | 1,000,000 | $2,028 萬 | 1.0% | −42,900−4.1% | 減碼 | 歷史 |
| SLNSilence Therapeutics plc | ADS | 1,951,580 | $1,958 萬 | 1.0% | +1,000,000+105.1% | 加碼 | 歷史 |
| FMTXForma Therapeutics Holdings, Inc. | SHS | 966,573 | $1,928 萬 | 1.0% | −3,083,427−76.1% | 減碼 | 歷史 |
| ARDXArdelyx, Inc. | COM | 14,858,000 | $1,768 萬 | 0.9% | +14,858,000 | 新進 | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 460,861 | $1,706 萬 | 0.8% | −39,139−7.8% | 減碼 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 300,000 | $1,679 萬 | 0.8% | +300,000 | 新進 | 歷史 |
| ETNB89bio, Inc. | COM | 2,636,000 | $1,526 萬 | 0.8% | +2,636,000 | 新進 | 歷史 |
| TCDATricida, Inc. | COM | 1,177,680 | $1,234 萬 | 0.6% | −1,554,437−56.9% | 減碼 | 歷史 |
| ACETAdicet Bio, Inc. | COM | 825,508 | $1,174 萬 | 0.6% | −66,520−7.5% | 減碼 | 歷史 |
| JNCEJounce Therapeutics, Inc. | COM | 4,259,653 | $996.8 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| KROSKeros Therapeutics, Inc. | COM | 248,500 | $934.9 萬 | 0.5% | −491,028−66.4% | 減碼 | 歷史 |
| ANABAnaptysbio, Inc | COM | 360,000 | $918.4 萬 | 0.5% | −312,569−46.5% | 減碼 | 歷史 |
| IPSCCentury Therapeutics, Inc. | COM | 924,641 | $914.5 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| INZYInozyme Pharma, Inc. | COM | 3,250,000 | $871.0 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| DNTHDianthus Therapeutics, Inc. | COM | 5,359,000 | $755.6 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| FULCFulcrum Therapeutics, Inc. | COM | 900,711 | $728.7 萬 | 0.4% | −99,289−9.9% | 減碼 | 歷史 |
| HOOKHOOKIPA Pharma Inc. | COM | 5,035,998 | $674.8 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| GHRSGH Research PLC | ORDINARY SHARES | 499,400 | $580.3 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| ASMBAssembly Biosciences, Inc. | COM | 3,000,000 | $492.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| SDGRSchrodinger, Inc. | COM | 170,000 | $424.7 萬 | 0.2% | −392,000−69.8% | 減碼 | 歷史 |
| PASGPassage BIO, Inc. | COM | 1,439,062 | $179.9 萬 | 0.1% | −880,938−38.0% | 減碼 | 歷史 |
| GRTSGritstone bio, Inc. | COM | 45,500 | $11.7 萬 | <0.1% | −1,674,500−97.4% | 減碼 | 歷史 |
選擇權（5 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2022 年第 2 季之後清倉（5 檔）
2022 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2022 年第 2 季股數 | 2022 年第 2 季市值 | 2022 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 905,000 | $6,478 萬 | 4.5% | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 1,733,130 | $2,442 萬 | 1.7% | 歷史 |
| SAGESage Therapeutics, Inc. | COM | 171,800 | $554.9 萬 | 0.4% | 歷史 |
| TNYATenaya Therapeutics, Inc. | COM | 483,836 | $272.4 萬 | 0.2% | 歷史 |
| ATYRaTYR PHARMA INC | COM NEW | 290,844 | $82.3 萬 | 0.1% | 歷史 |